News
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...
Pharmaceutical company Novo Nordisk is waiting on federal approval to sell its blockbuster GLP-1 weight-loss treatment as a ...
You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...
Andy Richter said he looked into taking weight-loss drugs despite not having type 2 diabetes. However, his insurance company ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...
The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...
Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...
When it came to cardiovascular incidents, the report showed major gains for GLP-1 users, too. 44% experienced fewer ...
Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...
The Mirror US on MSN3h
'I lost 46lbs and 5 dress sizes with weight loss jabs but there's one drawback no one tells you'A young mum has shared an honest account of her weight loss journey after her health took a frightening turn while surviving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback